Neurocrine Biosciences
NBIX
#1471
Rank
NZ$26.29 B
Marketcap
NZ$258.69
Share price
-0.51%
Change (1 day)
4.29%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company